MPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice

Biomedicine and Pharmacotherapy

Volumn 64, Issue 6, 2010, Pages 409-416

  Kamata, Hiroki ^a   Hosono, Kanako ^a   Suzuki, Tatsunori ^a   Ogawa, Yasufumi ^a   Kubo, Hidefumi ^a   Katoh, Hiroshi ^a   Ito, Yoshiya ^a   Uematsu, Satoshi ^b   Akira, Shizuo ^b   Watanabe, Masahiko ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Anginogenesis; Bone marrow derived cells; Cancer; MPGES 1

Indexed keywords

PROSTAGLANDIN E SYNTHASE 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CHIMERA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE 2; GRANULATION TISSUE; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954313418     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.01.017     Document Type: Article

References (34)

1. Amano H., Hayashi I., Endo H., Kitasato H., Yamashina S., Maruyama T., et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 2003, 197(2):221-232.
2. Fujita M., Hayashi I., Yamashina S., Fukamizu A., Itoman M., Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005, 26(2):271-279.
3. Ikeda Y., Hayashi I., Kamoshita E., Yamazaki A., Endo H., Ishihara K., et al. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 2004, 64(15):5178-5185.
4. Majima M., Amano H., Hayashi I. Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol Sci 2003, 24(10):524-529.
5. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867.
6. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7(11):1194-1201.
7. Giovannucci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995, 333(10):609-614.
8. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001, 1(1):11-21.
9. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87(5):803-809.
10. Katori M., Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000, 49(8):367-392.
11. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352(11):1092-1102.
12. Kamoshita E., Ikeda Y., Fujita M., Amano H., Oikawa A., Suzuki T., et al. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 2006, 169(4):1458-1472.
13. Jakobsson P.J., Thoren S., Morgenstern R., Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999, 96(13):7220-7225.
14. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000, 275(42):32783-32792.
15. Tanioka T., Nakatani Y., Semmyo N., Murakami M., Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000, 275(42):32775-32782.
16. Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K., Kojima M., et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 2002, 291(4):884-889.
17. Samuelsson B., Morgenstern R., Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007, 59(3):207-224.
18. Kamei D., Yamakawa K., Takegoshi Y., Mikami-Nakanishi M., Nakatani Y., Oh-Ishi S., et al. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem 2004, 279(32):33684-33695.
19. Katagiri H., Ito Y., Ishii K., Hayashi I., Suematsu M., Yamashina S., et al. Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology 2004, 39(1):139-150.
20. Yoshida S., Amano H., Hayashi I., Kitasato H., Kamata M., Inukai M., et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003, 83(10):1385-1394.
21. Majima M., Isono M., Ikeda Y., Hayashi I., Hatanaka K., Harada Y., et al. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn J Pharmacol 1997, 75(2):105-114.
22. Muramatsu M., Katada J., Hayashi I., Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 2000, 275(8):5545-5552.
23. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000, 130(3):641-649.
24. Hayashi I., Amano H., Yoshida S., Kamata K., Kamata M., Inukai M., et al. Suppressed angiogenesis in kininogen-deficiencies. Lab Invest 2002, 82(7):871-880.
25. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82(1):4-6.
26. Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5(12):1359-1364.
27. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86(3):353-364.
28. Uematsu S., Matsumoto M., Takeda K., Akira S. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 2002, 168(11):5811-5816.
29. Han R., Tsui S., Smith T.J. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem 2002, 277(19):16355-16364.
30. Naraba H., Yokoyama C., Tago N., Murakami M., Kudo I., Fueki M., et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 2002, 277(32):28601-28608.
31. Yoshimatsu K., Altorki N.K., Golijanin D., Zhang F., Jakobsson P.J., Dannenberg A.J., et al. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res 2001, 7(9):2669-2674.
32. Ogawa Y., Suzuki T., Oikawa A., Hosono K., Kubo H., Amano H., et al. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth. Biochem Biophys Res Commun 2009, 382(4):720-725.
33. Kamei D., Murakami M., Sasaki Y., Nakatani Y., Majima M., Ishikawa Y., et al. Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem J 2009.
34. Weiser-Evans M.C., Wang X.Q., Amin J., Van Putten V., Choudhary R., Winn R.A., et al. Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. Cancer Res 2009, 69(5):1733-1738.